IVF hartmann Holding AG
Company Profile
Business description
IVF hartmann Holding AG, along with its subsidiaries, engages in the production and supply of medical, pharmaceutical, and hygiene products in Switzerland. Its product portfolio comprises products for wound care, incontinence care, surgical supplies, and disinfection, as well as products for first aid and household management. Additional product segments such as cotton wool and medicated plasters are also offered. Furthermore, the Group develops and offers customized services. It operates in four segments: wound care, incontinence management, infection management, and others. Maximum revenue is derived from the wound care segment, which offers modern and traditional wound care products (including tactical emergency medicine) as well as first aid products.
Contact
Victor von Bruns-Strasse 28
Neuhausen am Rheinfall8212
CHET: +41 526743111
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
311
Stocks News & Analysis
stocks
CBA earnings: Business lending powers on, but costs and credit bear watching
stocks
Apple earnings review: Revenue beats estimates as memory crunch threatens margins
stocks
Nvidia: Cutting our fair value estimate by 19% given the firm’s CEO transition and turmoil
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,204.50 | 69.70 | -0.75% |
| CAC 40 | 8,368.91 | 7.55 | 0.09% |
| DAX 40 | 26,749.95 | 21.93 | -0.08% |
| Dow JONES (US) | 52,347.55 | 50.46 | 0.10% |
| FTSE 100 | 10,902.56 | 39.47 | 0.36% |
| HKSE | 23,637.60 | 370.95 | -1.55% |
| NASDAQ | 25,136.27 | 229.82 | -0.91% |
| Nikkei 225 | 61,142.35 | 322.99 | 0.53% |
| NZX 50 Index | 14,173.68 | 85.55 | -0.60% |
| S&P 500 | 7,561.67 | 30.73 | -0.40% |
| S&P/ASX 200 | 9,082.20 | 64.60 | -0.71% |
| SSE Composite Index | 3,634.35 | 21.48 | -0.59% |